racer
Rahal Letterman Lanigan Racings season of introducing new sponsors to the IndyCar Series with Mick Schumacher and the No.
47 Honda has a new addition with the signing of Vanda Pharmaceuticals as the primary for four of the seven remaining races.
The German will carry branding for Vandas Nereus, which treats symptoms of motion sickness, starting this weekend at Nashville with the Borchetta Bourbon Music Grand Prix and continue at Portland, Washington, D.C.
and Monterey.
We are proud to partner with the historic RLL racing team featuring our launch of Nereus with the No.
47 car driven by Mick Schumacher, which also celebrates 47 years since the last treatment approved in the United States for people with motion sickness, said Vanda CEO Mihael Polymeropoulos.
The companys first foray into motor racing with RLL complements its advertising and promotional efforts in the NHL, NBA, WNBA, college basketball, professional tennis and regional sports.
We are proud to partner with a company that is committed to helping people optimize their health and live healthier, more active lives, said Jay Frye, president of RLL.
We are especially excited to support this effort through their home race the Freedom 250 Grand Prix of Washington, D.C., a unique platform that allows us to raise awareness of an important health solution while engaging with fans in a meaningful way.
Marshall Pruett The 2026 season marks Marshall Pruett's 40th year working in the sport.
In his role today for RACER, Pruett covers open-wheel and sports car racing as a writer, reporter, photographer, and filmmaker.
In his previous career, he served as a mechanic, engineer, and team manager in a variety of series, including IndyCar, IMSA, and World Challenge.
Read Marshall Pruett's articles Latest News Comments Comments are disabled until you accept Social Networking Cookies.
Update cookie preferences If the dialog doesn't appear, ad-blockers are often the cause; try disabling yours or see our Social Features Support.